Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PharmaNet Canada and, Maisonneuve-Rosemont Hospital (HMR) and its Research Center have signed a pact for conducting pharmacokinetic studies in patients with impaired renal function.
Subscribe to our email newsletter
With this agreement, PharmaNet will have to access potential subjects who are suffering from mild, moderate, or severe impaired renal function.
PharmaNet Early Stage Development president Riaz Bandali said demand for the conduct of pharmacokinetic studies in patients with impaired renal function is increasing.
"By partnering with HMR, we can efficiently conduct trials in patients with various levels of renal impairment, while assuring the patients’ safety and well-being," Bandali said.